DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 EU WC

1 API Suppliers
1 EU WC

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 5964-37-4, 26g46g752s, 1-propanamine, 2-(1-(4-chlorophenyl)-1-phenylethoxy)-n,n-dimethyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1), 56050-03-4, 2-[1-(4-chlorophenyl)-1-phenylethoxy]-n,n-dimethylpropan-1-amine;2-hydroxypropane-1,2,3-tricarboxylic acid, Einecs 227-744-0

Molecular Formula

C₂₅H₃₂ClNO₈

Molecular Weight

510.0 g/mol

InChI Key

NWXYYVAVFTZHND-UHFFFAOYSA-N

FDA UNII

26G46G752S

1 2D Structure

Mecloxamine Citrate

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

2-[1-(4-chlorophenyl)-1-phenylethoxy]-N,N-dimethylpropan-1-amine;2-hydroxypropane-1,2,3-tricarboxylic acid

2.1.2 InChI

InChI=1S/C19H24ClNO.C6H8O7/c1-15(14-21(3)4)22-19(2,16-8-6-5-7-9-16)17-10-12-18(20)13-11-17;7-3(8)1-6(13,5(11)12)2-4(9)10/h5-13,15H,14H2,1-4H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)

2.1.3 InChI Key

NWXYYVAVFTZHND-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CC(CN(C)C)OC(C)(C1=CC=CC=C1)C2=CC=C(C=C2)Cl.C(C(=O)O)C(CC(=O)O)(C(=O)O)O

2.2 Other Identifiers

2.2.1 UNII

26G46G752S

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. 5964-37-4

2. 26g46g752s

3. 1-propanamine, 2-(1-(4-chlorophenyl)-1-phenylethoxy)-n,n-dimethyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)

4. 56050-03-4

5. 2-[1-(4-chlorophenyl)-1-phenylethoxy]-n,n-dimethylpropan-1-amine;2-hydroxypropane-1,2,3-tricarboxylic Acid

6. Einecs 227-744-0

7. Unii-26g46g752s

8. Schembl5705589

9. Dtxsid70975034

10. Mecloxamine Citrate [who-dd]

11. Q27254093

12. 2-hydroxypropane-1,2,3-tricarboxylic Acid--2-[1-(4-chlorophenyl)-1-phenylethoxy]-n,n-dimethylpropan-1-amine (1/1)

2.4 Create Date

2006-04-29

3 Chemical and Physical Properties

Molecular Formula	C₂₅H₃₂ClNO₈
Molecular Weight	510.0 g/mol
Hydrogen Bond Donor Count	4
Hydrogen Bond Acceptor Count	9
Rotatable Bond Count	11
Exact Mass	509.1816447 g/mol
Monoisotopic Mass	509.1816447 g/mol
Topological Polar Surface Area	145 Å²
Heavy Atom Count	35
Formal Charge	0
Complexity	549
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	2
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2